Who owns ACHIEVE LIFE SCIENCES INC?
- Ticker: ACHV
- CUSIP Number: 004468500
Tip: Access positions for across all investors
Analyze quarterly positions in Achieve Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Achieve Life Sciences stock
Who bought or sold ACHIEVE LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 4.4M | $13M | 0% | Mar 2026 |
|
| Propel Bio Management | 3.8M | $11M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 2.2M | $6.5M | 100% | Mar 2026 |
|
| Simplify Asset Management | 1.4M | $9.4M | 21% | Jun 2026 |
|
| Millennium Management | 1.1M | $3.2M | -21% | Mar 2026 |
|
| Marshall Wace | 1.0M | $3.0M | 0% | Mar 2026 |
|
| LPL Financial | 728k | $2.1M | 15% | Mar 2026 |
|
| Nantahala Capital Management | 649k | $1.9M | 0% | Mar 2026 |
|
| Raymond James Financial | 642k | $1.9M | 7% | Mar 2026 |
|
| Geode Capital Management | 623k | $1.8M | 4% | Mar 2026 |
|
| Two Sigma Investments | 589k | $1.7M | -21% | Mar 2026 |
|
| Susquehanna International | 511k | $1.5M | -8% | Mar 2026 |
|
| KVP Capital Advisors | 462k | $1.4M | 0% | Mar 2026 |
|
| BlackRock | 439k | $1.3M | 5% | Mar 2026 |
|
| UBS Group | 326k | $959k | 14% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 316k | $930k | 100% | Mar 2026 |
|
| State Street Corporation | 255k | $748k | 9% | Mar 2026 |
|
| Northern Trust | 225k | $661k | -2% | Mar 2026 |
|
| Shay Capital | 205k | $603k | 100% | Mar 2026 |
|
| Citadel Advisors | 203k | $596k | 83% | Mar 2026 |
|
| 683 Capital Management | 200k | $588k | -7% | Mar 2026 |
|
| Jane Street | 177k | $519k | -55% | Mar 2026 |
|
| Goldman Sachs Group | 153k | $450k | -66% | Mar 2026 |
|
| Foundations Investment Advisors | 145k | $426k | 100% | Mar 2026 |
|
| Lakeside Advisors | 111k | $327k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 102k | $300k | 46% | Mar 2026 |
|
| Ronald Blue Trust | 86k | $253k | 0% | Mar 2026 |
|
| Hudson Bay Capital Management | 85k | $250k | 25% | Mar 2026 |
|
| Bank of America Corporation | 71k | $208k | 100% | Mar 2026 |
|
| Morgan Stanley | 70k | $207k | -11% | Mar 2026 |
|
| Manchester Financial | 67k | $439k | 1% | Jun 2026 |
|
| Members Wealth | 67k | $436k | 123% | Jun 2026 |
|
| Advisor Group Holdings | 56k | $165k | 4% | Mar 2026 |
|
| Brevan Howard Capital Management | 55k | $160k | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 52k | $154k | 0% | Mar 2026 |
|
| Alpine Partners VI | 50k | $147k | -40% | Mar 2026 |
|
| Barclays | 48k | $141k | -56% | Mar 2026 |
|
| ADAR1 Capital Management | 48k | $141k | 0% | Mar 2026 |
|
| Charles Schwab Investment Management | 43k | $126k | 115% | Mar 2026 |
|
| Point72 Asset Management | 38k | $111k | -50% | Mar 2026 |
|
| Next Capital Management | 35k | $103k | 117% | Mar 2026 |
|
| Hrt Financial | 32k | $92k | 67% | Mar 2026 |
|
| Caption Management | 30k | $89k | -55% | Mar 2026 |
|
| Rockefeller Capital Management | 30k | $88k | 0% | Mar 2026 |
|
| Renaissance Technologies | 28k | $82k | -82% | Mar 2026 |
|
| BCV Asset Management | 26k | $78k | 100% | Mar 2026 |
|
| Keating Financial Advisory Services | 25k | $73k | 100% | Mar 2026 |
|
| Goldstone Financial Group | 24k | $71k | 0% | Mar 2026 |
|
| Magnolia Capital Advisors | 24k | $71k | 88% | Mar 2026 |
|
| Vanguard Global Advisers | 23k | $67k | 100% | Mar 2026 |
|
| Scientech Research | 22k | $64k | 100% | Mar 2026 |
|
| Robertson Stephens Wealth Management | 20k | $59k | 0% | Mar 2026 |
|
| Squarepoint Ops | 20k | $58k | -88% | Mar 2026 |
|
| Diametric Capital | 19k | $55k | 100% | Mar 2026 |
|
| XTX Topco | 18k | $54k | -5% | Mar 2026 |
|
| Catalyst Funds Management Pty | 18k | $53k | 100% | Mar 2026 |
|
| Axq Capital | 15k | $45k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 14k | $42k | 100% | Mar 2026 |
|
| nVerses Capital | 14k | $42k | 100% | Mar 2026 |
|
| SBI Securities | 14k | $42k | 0% | Mar 2026 |
|
| Leucadia National Corporation | 13k | $37k | -25% | Mar 2026 |
|
| Windsor Capital Management | 11k | $71k | 0% | Jun 2026 |
|
| FMR | 5.9k | $17k | -9% | Mar 2026 |
|
| Citigroup | 5.4k | $16k | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 3.0k | $8.8k | 0% | Mar 2026 |
|
| Fifth Third Bancorp | 2.3k | $6.7k | 100% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 2.0k | $5.9k | 0% | Mar 2026 |
|
| CWM | 1.7k | $5.0k | 0% | Mar 2026 |
|
| Capital Analysts | 700.00 | $2.0k | 0% | Mar 2026 |
|
| Sittner & Nelson | 673.00 | $2.0k | 0% | Mar 2026 |
|
| Efficient Wealth Management | 500.00 | $1.0k | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 500.00 | $1.3k | 150% | Mar 2026 |
|
| Optiver Holding B.V. | 490.00 | $1.4k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 254.00 | $746.988600 | -100% | Mar 2026 |
|
| Steward Partners Investment Advisory | 215.00 | $631.992500 | -95% | Mar 2026 |
|
| Russell Investments | 150.00 | $441.000000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 126.00 | $0 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $6.000000 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 1.00 | $29.000000 | -90% | Mar 2026 |
|
Who sold out of Achieve Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pathstone Holdings | Dec 2025 | 417k | $1.9M |
| None | Dec 2025 | 235k | $1.2M |
| Two Sigma Advisers | Dec 2025 | 210k | $1.0M |
| SLT Holdings | Mar 2026 | 143k | $420k |
| Graham Capital Management | Dec 2025 | 43k | $212k |
| Lighthouse Investment Partners | Dec 2025 | 24k | $118k |
| Jump Financial | Dec 2025 | 21k | $104k |
| Simplex Trading | Dec 2025 | 17k | $86k |
| Qube Research & Technologies | Dec 2025 | 13k | $67k |
| Madison Park Capital Advisors | Mar 2026 | 10k | $29k |
| Tower Research Capital | Dec 2025 | 2.8k | $14k |
| Cornerstone Planning Group | Dec 2025 | 100.00 | $436.000000 |
| Parkside Financial Bank & Trust | Dec 2025 | 5.00 | $25.000000 |